The Scientist

» quantitative PCR, ecology and disease/medicine

Most Recent

image: The Brain on Anesthetics

The Brain on Anesthetics

By | November 5, 2012

Recording brain activity as patients are anesthetized for surgery, researchers identify a pattern that may signal loss of consciousness.  

1 Comment

image: Gingers More Prone to Skin Cancer

Gingers More Prone to Skin Cancer

By | November 2, 2012

Researchers identify an unexpected molecular explanation for the higher incidence of skin cancer in redheads.

5 Comments

image: Contributors

Contributors

By | November 1, 2012

Meet some of the people featured in the November 2012 issue of The Scientist.

0 Comments

image: Little Fish in a Big Pond

Little Fish in a Big Pond

By | November 1, 2012

Continued overfishing of forage fish such as sardines and herring can result in devastating ecological and economic outcomes.

1 Comment

image: Microbial Awakening

Microbial Awakening

By | November 1, 2012

Successive awakening of soil microbes drives a huge pulse of CO2 following the first rain after a dry summer.

1 Comment

image: Omega-3s: Fishing for a Mechanism

Omega-3s: Fishing for a Mechanism

By | November 1, 2012

Despite abundant evidence supporting their ability to help prevent and treat cardiovascular disease, the therapeutic effectiveness of fish oil–derived fatty acids remains controversial.

4 Comments

image: PCR Usage and Preferences

PCR Usage and Preferences

By | November 1, 2012

Quantitative real-time technology dominates the market today but digital PCR is on the rise.

0 Comments

image: The Birthday Conference

The Birthday Conference

By | November 1, 2012

Snapshots from an annual meeting that celebrates the birth of a prominent biologist

0 Comments

image: The Road Less Traveled

The Road Less Traveled

By | November 1, 2012

First, Aravinda Chakravarti drew a map of how scientists might unravel the genetics of complex disease. Then he blazed the trail.

0 Comments

image: Tumor Snipers

Tumor Snipers

By | November 1, 2012

After two headline successes, companies rush to develop “smart bomb” cancer drugs.

0 Comments

Popular Now

  1. GM Mosquitoes Closer to Release in U.S.
  2. Effects of Neanderthal DNA on Modern Humans
  3. Flux and Uncertainty in the CRISPR Patent Landscape
  4. Do Pathogens Gain Virulence as Hosts Become More Resistant?
RayBiotech